Healios K.K. 6VX.F Stock
Healios K.K. Price Chart
Healios K.K. 6VX.F Financial and Trading Overview
| Healios K.K. stock price | 0.99 EUR |
| Previous Close | 1.89 EUR |
| Open | 1.89 EUR |
| Bid | 1.89 EUR x N/A |
| Ask | 2 EUR x N/A |
| Day's Range | 1.89 - 1.89 EUR |
| 52 Week Range | 1.7 - 2.86 EUR |
| Volume | 380 EUR |
| Avg. Volume | 31 EUR |
| Market Cap | 122.69M EUR |
| Beta (5Y Monthly) | 0.869731 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.44 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6VX.F Valuation Measures
| Enterprise Value | 102.32M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.4266775 |
| Price/Book (mrq) | 0.031224187 |
| Enterprise Value/Revenue | 1.19 |
| Enterprise Value/EBITDA | -0.024 |
Trading Information
Healios K.K. Stock Price History
| Beta (5Y Monthly) | 0.869731 |
| 52-Week Change | -19.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.86 EUR |
| 52 Week Low | 1.7 EUR |
| 50-Day Moving Average | 2.01 EUR |
| 200-Day Moving Average | 2.05 EUR |
6VX.F Share Statistics
| Avg. Volume (3 month) | 31 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 63.65M |
| Float | 29.99M |
| Short Ratio | N/A |
| % Held by Insiders | 51.07% |
| % Held by Institutions | 15.28% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -5368.60% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.31% |
| Return on Equity (ttm) | -83.34% |
Income Statement
| Revenue (ttm) | 86M EUR |
| Revenue Per Share (ttm) | 1.46 EUR |
| Quarterly Revenue Growth (yoy) | -36.39% |
| Gross Profit (ttm) | 90M EUR |
| EBITDA | -4180000000 EUR |
| Net Income Avi to Common (ttm) | -4440999936 EUR |
| Diluted EPS (ttm) | -0.61 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.16B EUR |
| Total Cash Per Share (mrq) | 112.42 EUR |
| Total Debt (mrq) | 7.13B EUR |
| Total Debt/Equity (mrq) | 184.47 EUR |
| Current Ratio (mrq) | 2.261 |
| Book Value Per Share (mrq) | 60.53 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3913999872 EUR |
| Levered Free Cash Flow (ttm) | -2776250112 EUR |
Profile of Healios K.K.
| Country | Germany |
| State | N/A |
| City | Tokyo |
| Address | Yurakucho Denki Building |
| ZIP | 100-0006 |
| Phone | N/A |
| Website | https://www.healios.co.jp |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 71 |
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration; HLCL041, an iPSC regenerative medicine for the treatment of metabolic liver disease; and HLCM051, a regenerative medicine for treatment of ischemic stroke and acute respiratory distress syndrome, as well as HLCN061 for treating solid tumors. Healios K.K. has a joint research agreement with the Hyogo Medical University on cancer immunotherapies for mesothelioma using eNK cells. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan.
Q&A For Healios K.K. Stock
What is a current 6VX.F stock price?
Healios K.K. 6VX.F stock price today per share is 0.99 EUR.
How to purchase Healios K.K. stock?
You can buy 6VX.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Healios K.K.?
The stock symbol or ticker of Healios K.K. is 6VX.F.
Which industry does the Healios K.K. company belong to?
The Healios K.K. industry is Biotechnology.
How many shares does Healios K.K. have in circulation?
The max supply of Healios K.K. shares is 92.24M.
What is Healios K.K. Price to Earnings Ratio (PE Ratio)?
Healios K.K. PE Ratio is now.
What was Healios K.K. earnings per share over the trailing 12 months (TTM)?
Healios K.K. EPS is -0.44 EUR over the trailing 12 months.
Which sector does the Healios K.K. company belong to?
The Healios K.K. sector is Healthcare.